1. CLAPO syndrome: Effective response to treatment with oral rapamycin.
- Author
-
González-Hermosa MR, Guerra E, Tuduri I, Vicente I, and López-Almaraz R
- Subjects
- Administration, Oral, Arteriovenous Malformations physiopathology, Humans, Immunosuppressive Agents adverse effects, Infant, Newborn, Lymphatic Diseases physiopathology, Male, Sirolimus adverse effects, Treatment Outcome, Arteriovenous Malformations drug therapy, Immunosuppressive Agents administration & dosage, Lymphatic Diseases drug therapy, Sirolimus administration & dosage
- Abstract
CLAPO syndrome (Capillary vascular malformation of the lower lip, Lymphatic malformations of the head and neck, Asymmetry and Partial or generalized Overgrowth) is a nonfrequent pathology. This syndrome is characterized by the capillary malformation (CM) of the lower lip, a very important clinical sign when diagnosing CLAPO. The aim of our report is to demonstrate that rapamycin could be a reliable and safe targeted therapy in lymphatic malformations (LMs). This drug is useful in reducing the LM's size before final surgical treatment. The clinical and radiological evolution of a patient with CLAPO syndrome is reported in this article, before and after the treatment with rapamycin., (© 2019 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF